Hiltonol

Identification

Generic Name

Hiltonol

DrugBank Accession Number

DB17293

Background

Not Available

Type

Biotech

Groups

Investigational

Synonyms

5'-cytidylic acid, homopolymer, complex with 5'-inosinic acid homopolymer (1:1), compd. with cellulose carboxymethyl ether and l-lysine homopolymer
5'-inosinic acid, homopolymer, complex with 5'-cytidylic acid homopolymer (1:1), compd. with cellulose carboxymethyl ether and l-lysine homopolymer
L-lysine, homopolymer, compd. with cellulose carboxymethyl ether and 5'-inosinic acid homopolymer complex with 5'-cytidylic acid homopolymer
Poly-IC with poly-lysine
Poly-ICLC
Poly(ICLC)

Indication: Not Available
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings: Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Clinical Trials

Phase	Status	Purpose	Conditions	Count
2	Completed	Prevention	Risk for Colorectal Cancer	1
2	Completed	Treatment	Central Nervous System Neoplasm	1
2	Completed	Treatment	Cutaneous Melanoma / Melanoma / Melanoma of Unknown Primary / Mucosal Melanoma / Ocular Melanoma / Stage IIB Cutaneous Melanoma AJCC v6 and v7 / Stage IIC Cutaneous Melanoma AJCC v6 and v7 / Stage III Cutaneous Melanoma AJCC v7 / Stage IIIA Cutaneous Melanoma AJCC v7 / Stage IIIB Cutaneous Melanoma AJCC v7 / Stage IIIC Cutaneous Melanoma AJCC v7 / Stage IV Cutaneous Melanoma AJCC v6 and v7	1
2	Completed	Treatment	Head And Neck Cancer / Melanoma / Non-Melanoma Skin Cancer / Sarcomas	1
2	Completed	Treatment	Melanoma	1
2	Completed	Treatment	Multiple Myeloma (MM)	1
2	Completed	Treatment	Neoplasm	1
2	Completed	Treatment	Squamous Cell Carcinoma of the Oral Cavity	1
2	Recruiting	Treatment	Anatomic Stage IV Breast Cancer AJCC v8 / Invasive Breast Carcinoma / Metastatic Triple Negative Breast Cancers	1
2	Recruiting	Treatment	Low-Grade Glioma	1

Drug created at December 02, 2022 18:09 / Updated at December 03, 2022 09:37